Results 371 to 380 of about 297,887 (387)
Some of the next articles are maybe not open access.

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

The Lancet, 1998
R. Turner   +13 more
semanticscholar   +1 more source

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

Nature Network Boston, 2017
Hao Wu   +17 more
semanticscholar   +1 more source

[Metformin and kidney].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2016
Metformin is the first choice among drugs used for the treatment of type II diabetes mellitus mainly because of several advantages: proven hypoglycemic effect, good safety profile, virtually no risk of hypoglycemia, body weight reduction, lipid-lowering effect, efficacy in preventing micro- and macrovascular complications as well as adverse cardiac and
Sessa C   +5 more
openaire   +2 more sources

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

Nature Reviews Endocrinology, 2019
M. Foretz, B. Guigas, B. Viollet
semanticscholar   +1 more source

Metformin☆

2007
Caroline Day, Clifford J. Bailey
openaire   +1 more source

METFORMIN PRECAUTION

American Journal of Nursing, 1996
openaire   +2 more sources

Diabetics on metformin

Clinical Radiology, 1998
N. Hudson   +9 more
openaire   +3 more sources

Metformin

Reactions weekly, 2019

semanticscholar   +1 more source

Metformin Hepatotoxicity

Annals of Internal Medicine, 2004
M, Deutsch, D, Kountouras, S P, Dourakis
openaire   +2 more sources

Obesity and metformin

Journal of Pediatric Endocrinology and Metabolism, 2012
openaire   +3 more sources

Home - About - Disclaimer - Privacy